Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Approved
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
4 competitors in Achondroplasia
View Full LandscapeTarget Indication
Achondroplasia
Mechanism of Action
C-type Natriuretic Peptide Analog
Clinical Trial
NCT03197766Last updated: 12/3/2025
Latest Patent Expiry
Patents Listed
8
Exclusivity
Application
NDA 214938Voxzogo
Voxzogo is indicated for the treatment of achondroplasia in patients 4 months of age and older whose epiphyses are not closed. The diagnosis of achondroplasia should be confirmed by appropriate genetic testing.
Phenylketonurias
Mucopolysaccharidosis IV A
Pain, Post-operative
Anemia Associated With End Stage Renal Disease
Hemophilia A With Inhibitor